Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naoki Omachi
Observed names:
N. Omachi,
NAOKI OMACHI
Institution:
Eishinkai Kishiwada Rehabilitation Hospital
Observed institutions:
University of Tsukuba,
NHO Kinki Chuo Chest Medical Center,
Eishinkai Kishiwada Rehabilitation Hospital,
The University of Tokyo
ORCID:
0000-0001-5414-1157
Observed ORCID:
0000-0001-5414-1157
OpenAlex ID:
A5085033046
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Beyond Progressive Disease: A Retrospective Analysis for Japanese Patients with Activating EGFR Mutations
2012
·
Kenichi Nishie
, Tomoya Kawaguchi
, et al.
·
Journal of Thoracic Oncology
·
104
Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study
2017
·
AKIHIRO TAMIYA
, MOTOHIRO TAMIYA
, et al.
·
Anticancer Research
·
92
PDF
Spinal Cord Infarction after Bronchial Artery Embolization for Hemoptysis: A Nationwide Observational Study in Japan
2021
·
Hideo Ishikawa
, Hiroyuki Ohbe
, et al.
·
Radiology
·
64
A Case of Large-Cell Neuroendocrine Carcinoma Harboring an EML4–ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib
2014
·
Naoki Omachi
, Shigeki Shimizu
, et al.
·
Journal of Thoracic Oncology
·
60
Impact of metastatic status on the prognosis of EGFR mutation‑positive non‑small cell lung cancer patients treated with first‑generation EGFR‑tyrosine kinase inhibitors
2017
·
Yoshihiko Taniguchi
, Akihiro Tamiya
, et al.
·
Oncology Letters
·
48
PDF
Mechanisms of recurrent haemoptysis after super-selective bronchial artery coil embolisation: a single-centre retrospective observational study
2018
·
Misaki Ryuge
, Masahiko Hara
, et al.
·
European Radiology
·
38
PDF
Continued treatment with gefitinib beyond progressive disease benefits patients with activating EGFR mutations
2012
·
Kazuhiro Asami
, Tomohisa Okuma
, et al.
·
Lung Cancer
·
35
Prevalence of non-bronchial systemic culprit arteries in patients with hemoptysis with bronchiectasis and chronic pulmonary infection who underwent de novo bronchial artery embolization
2022
·
Takashi Nishihara
, Hideo Ishikawa
, et al.
·
European Radiology
·
22
Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
2016
·
Motohiro Tamiya
, Akihiro Tamiya
, et al.
·
PubMed
·
20
Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysis
2017
·
Yujiro Naito
, Akihiro Tamiya
, et al.
·
Medicine
·
19
Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations
2015
·
Akihiro Tamiya
, Motohiro Tamiya
, et al.
·
Medical Oncology
·
18
Combination of virtual bronchoscopic navigation, endobronchial ultrasound, and rapid on-site evaluation for diagnosing small peripheral pulmonary lesions: a prospective phase II study
2017
·
Toshiya Maekura
, Chikatoshi Sugimoto
, et al.
·
Journal of Thoracic Disease
·
17
PDF
Life-threatening and Rapidly Growing Teratoma in the Anterior Mediastinum
2015
·
Naoki Omachi
, Tomoya Kawaguchi
, et al.
·
Internal Medicine
·
16
PDF
Bronchial Artery Aneurysm: Prevalence, Clinical Characteristics, and Long-Term Prognosis Following Bronchial Artery Embolization
2021
·
Naoki Omachi
, Hideo Ishikawa
, et al.
·
Journal of Vascular and Interventional Radiology
·
13
The impact of bronchial artery embolisation on the quality of life of patients with haemoptysis: a prospective observational study
2021
·
Naoki Omachi
, Hideo Ishikawa
, et al.
·
European Radiology
·
13
PDF
Erratic coil migration in the bronchus after bronchial artery embolization
2019
·
Hideo Ishikawa
, Naoki Omachi
, et al.
·
Respirology Case Reports
·
13
Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer
2016
·
Masahiro Morimoto
, Kyoichi Okishio
, et al.
·
Clinical Lung Cancer
·
8
PDF
Afatinib efficacy and cerebrospinal fluid concentration in NSCLC patients with EGFR mutation developing leptomeningeal carcinomatosis
2016
·
A. Tamiya
, M. Tamiya
, et al.
·
Annals of Oncology
·
8
PDF
Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
2014
·
SHUN-ICHI ISA
, YU KURAHARA
, et al.
·
Oncology Letters
·
8
PDF
The efficacy of a reduced dose (40mg) of osimertinib with T790M-positive advanced non-small-cell lung cancer
2017
·
S. Sonobe
, Y. Taniguchi
, et al.
·
Annals of Oncology
·
7
OA08.05 Efficacy and Cerebrospinal Fluid Concentration of Afatinib in NSCLC Patients with EGFR Mutation Developing Leptomeningeal Carcinomatosis
2017
·
Akihiro Tamiya
, Motohiro Tamiya
, et al.
·
Journal of Thoracic Oncology
·
7
A Technical Manual of Bronchial Artery Embolization by Coil for Pulmonologists: An Expert's Opinion
2023
·
Hideo Ishikawa
, Yu Yamaguchi
, et al.
·
Respiratory Endoscopy
·
6
PDF
Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations
2017
·
Motohiro Tamiya
, Akihiro Tamiya
, et al.
·
Investigational New Drugs
·
3
Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non‐squamous cell non‐small cell lung cancer in J apan
2014
·
Kazuhiro Asami
, Masaaki Kawahara
, et al.
·
Thoracic Cancer
·
2
PDF
Overall Treatment Time of Accelerated Hyperfractionated Radiation Therapy at 45 Gy in 30 Fractions for Limited Small Cell Lung Cancer Is a Significant Prognostic Factor
2014
·
M. Morimoto
, S. Atagi
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
Show more works
View as search
Works count:
38
Citation count:
643
H-index:
13
I10-index:
16
Year
Topic
Type